English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/129003
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Coenzyme Q10: A novel therapeutic approach for Fibromyalgia? Case series with 5 patients

AuthorsCordero, Mario D. ; Alcocer-Gómez, Elísabet; Miguel, Manuel de; Cano-García, Francisco J.; Luque, Carlos M. ; Fernández-Riejo, Patricia; Moreno-Fernández, Ana M.; Sánchez-Alcázar, José Antonio
KeywordsLipid peroxidation
Fibromyalgia
Coenzyme Q10
Antioxidants
Issue Date2011
PublisherElsevier
CitationMitochondrion 11(4): 623-625 (2011)
AbstractCoenzyme Q10 (CoQ10) is an essential electron carrier in the mitochondrial respiratory chain and a strong antioxidant. Low CoQ10 levels have been detected in patients with Fibromyalgia (FM). The purpose of the present work was to assess the effect of CoQ10 on symptoms of five patients with FM. Patients were evaluated clinically with Visual Analogical Scale of pain (VAS), and Fibromyalgia Impact Questionnaire (FIQ). Patients with CoQ10 deficiency showed a statistically significant reduction on symptoms after CoQ10 treatment during 9months (300mg/day). Determination of deficiency and consequent supplementation in FM may result in clinical improvement. Further analysis involving more scientifically rigorous methodology will be required to confirm this observation.
URIhttp://hdl.handle.net/10261/129003
DOI10.1016/j.mito.2011.03.122
Identifiersdoi: 10.1016/j.mito.2011.03.122
issn: 1567-7249
e-issn: 1872-8278
Appears in Collections:(CABD) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.